Skip to main content
. 2015 May 12;17(10):1393–1401. doi: 10.1093/neuonc/nov084

Table 3.

Least squares estimates of fatigue and sleepiness at each time and post-randomization treatment differences

Outcome Time Armodafinil Control Difference in LS Mean (90% CI)
LS Mean (SE) LS Mean (SE)
FACIT-Fatigue Baseline 36.2 (1.55) 36.2 (1.55)
EndRT 30.9 (2.74) 32.1 (2.56) −1.25 (−7.28 to 4.78)
4wpRT 32.0 (2.56) 36.0 (2.52) −3.99 (−9.86 to 1.88)
BFI Baseline 2.97 (0.32) 2.97 (0.32)
EndRT 3.88 (0.58) 3.97 (0.54) −0.10 (−1.38 to 1.18)
4wpRT 3.71 (0.57) 3.29 (0.55) 0.42 (−0.85 to 1.69)
ESS Baseline 7.72 (0.59) 7.72 (0.59)
EndRT 7.70 (1.02) 8.24 (0.92) −0.54 (−2.77 to 1.70)
4wpRT 7.26 (1.03) 8.37 (1.00) −1.11 (−3.47 to 1.26)
Greater fatigue at baseline
 FACIT-Fatigue Baseline 27.1 (1.89) 27.1 (1.89)
EndRT 31.5 (2.53) 23.2 (3.28) 8.24 (2.16–14.3)
4wpRT 31.9 (3.45) 28.3 (5.10) 3.62 (−6.56 to 13.8)
Lesser fatigue at baseline
 FACIT-Fatigue Baseline 44.7 (0.77) 44.7 (0.77)
EndRT 24.9 (4.74) 38.8 (3.15) −13.9 (−23.6 to −4.11)
4wpRT 29.2 (3.92) 41.4 (2.77) −12.2 (−20.4 to −4.02)

Abbreviations: 4wpRT, 4 weeks post radiation therapy; BFI, Brief Fatigue Inventory; CI, confidence interval; EndRT, end of radiation therapy assessment; ESS, FACIT, Functional Assessment of Chronic Illness Therapy; LS, least squares; SE, standard error Epworth Sleepiness Scale.

Lower scores in the FACIT-Fatigue indicate worse symptoms, while higher scores in the BFI and ESS indicate worse symptoms.